In view of these amendments to Regulation (EU) 2021/953, in order to ensure the interoperability of the EU Digital COVID Certificate, the rules for populating the EU Digital COVID Certificate should be updated to reflect the possibility to use laboratory-based antigenic assays for test and recovery certificates and to issue vaccination certificates for participants in clinical trials.
Recital 6, Decision_act (EU) 2022/1516
In forcesince 8 Sep 2022
- celex=32021R0953